Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.
Yang M, Kondo T, Talebi A, Jhund PS, Docherty KF, Claggett BL, Vaduganathan M, Bachus E, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Kosiborod MN, Desai AS, Køber L, Ponikowski P, Sabatine MS, Solomon SD, McMurray JJV.
Yang M, et al. Among authors: solomon sd.
Eur J Heart Fail. 2024 May 3. doi: 10.1002/ejhf.3263. Online ahead of print.
Eur J Heart Fail. 2024.
PMID: 38700986